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The Transcription Factor NF-ATc1
Regulates Lymphocyte Proliferation
and Th2 Cytokine Production
(Flanagan et al., 1991; McCaffrey et al., 1993a, 1993b;
Ho et al., 1996; Beals et al., 1997) and, coupled with
the inducible nuclear component composed of AP-1
transcription factors (Flanagan et al., 1991; Jain et al.,
1992), binds to the promoter regions of multiple genes
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NF-ATc2, a member of the family, is expressed consti-
tutively in resting immune cells. Disruption of the NF-Summary
ATc2 gene revealed its role in the regulation of IL-4
production and the establishment of T helper-2 (Th2)NF-ATc1 is amember of a family of genes that encodes
responses (Hodge et al., 1996; Xanthoudakis et al.,the cytoplasmic component of the nuclear factor of
1996). NF-ATc1 is expressed in thymus and in lymphoidactivated T cells (NF-AT). In activated T cells, nuclear
organs, and its transcripts are markedly increased inNF-AT binds to the promoter regions of multiple cyto-
stimulated T cellsand thymocytes (Northrop et al.,1994).kine genes and induces their transcription. The role of
NF-ATc1 has also been shown to contribute to the pro-NF-ATc1 was investigated in recombination activating
duction of IL-2. The expression of full-length NF-ATc1gene-1 (RAG-1)±deficient blastocyst complementa-
cDNA activates the IL-2 promoter in non±T lymphocytes,tion assays using homozygous NF-ATc12/2 mutant ES
whereas expression of the dominant negative form ofcell lines. NF-ATc12/2/RAG-12/2 chimeric mice showed
NF-ATc1 blocks the IL-2 promoter. These data havereduced numbers of thymocytes and impaired prolifer-
suggested a function for NF-ATc1 in the developmentation of peripheral lymphocytes, but normal produc-
and activation of T lymphocytes as well as in the produc-tion of IL-2. Induction in vitro of Th2 responses, as
tion of IL-2 by T cells.demonstrated by a decrease in IL-4 and IL-6 produc-
To address whether NF-ATc1 plays specific roles intion, was impaired in mutant T cells. These data indi-
lymphocyte development and activation, we generatedcate that NF-ATc1 plays roles in the development of
embryonic stem (ES) cell lines with a homozygous muta-T lymphocytes and in the differentiation of the Th2
tion in the NF-ATc1 gene and analyzed the developmentresponse.
and function of lymphocytes in recombination activating
gene-1 (RAG-1)±deficient blastocyst complementation
assays (Chen et al., 1993, 1994a). Mutant lymphocytesIntroduction
exhibited decreased proliferation compared to control
cells and showed impaired production of Th2-type cyto-Nuclear factor of activated T cells (NF-AT) was first de-
scribed as a transcriptional regulatory complex critical kines in an in vitro differentiation assay. These results
indicate that NF-ATc1 is required for the development offor the expression of the T cell cytokine interleukin-2
(IL-2) (Shaw et al., 1988). Subsequently, NF-AT has been T lymphocytes and the differentiation of Th2 responses.
shown to play a role in the induction of multiple genes
encoding cytokines and cell surface receptors such as Results
CD40L and FasL in activated lymphocytes (Durand et
al., 1988; Cockerill et al., 1993; Goldfeld et al., 1993; Generation of NF-ATc1 Mutant Cell Lines
Rooney et al., 1995; Hodge et al., 1996; Tsytsykova et and NF-ATc12/2/RAG-12/2 Chimeric Mice
al., 1996). In activated lymphocytes, NF-AT translocates Mutant mouse ES cell lines in which exon 3 of the NF-
from the cytoplasm into the nucleus (Shibasaki et al., ATc1 gene was disrupted by homologous recombina-
1996; Timmerman et al., 1996; Liu et al., 1997) after tion were generated (unpublished data). Homozygous
cyclosporin-sensitive dephosphorylation by calcineurin NF-ATc12/2 mutant mice die before day 14.5 of em-
bryogenesis from congestive heart failure (unpublished
data), preventing the analysis of NF-ATc function in lym-§To whom correspondence should be addressed (e-mail: t.mak@
oci.utoronto.ca). phocytes of these animals. To circumvent this situation,
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ES cell clone were injected into RAG-12/2 blastocysts.
Because the E14 ES cells used for gene targeting are
derived from a strain 129 mouse background, age-
matched 129/J mice were used as wild-type controls.
Both heterozygous and homozygous ES cell clones
were able to reconstitute the T and B cell compartments
of RAG-12/2 mice. The lymph nodes and spleens of NF-
ATc12/2 chimeras had normal cell numbers (Table 1).
To confirm that mature lymphocytes in the chimeras
were derived from the injected ES cells, CD41 thymo-
cytes were cell-sorted and genotyped by the polymer-
ase chain reaction (PCR) technique (Figure 1B). The
absence of NF-ATc1 mRNA in activated T cells from NF-
ATc12/2/RAG-12/2 chimeras was confirmed by Northern
blot analysis (Figure 1C). Genotyping of the organs of
the chimeras showed that the injected ES cell clones
were able to differentiate into multiple organs (Figure
1D). All chimeric mice appeared to be healthy and
showed no anomalies in gross anatomical examinations.
Reduction in the Number of Thymocytes and Impaired
Proliferation of the Thymocyte Precursor
Population in the Mutant Chimeric Mice
The thymi of NF-ATc12/2 chimeric mice were more than
twice as small as thymi of age-matched 129/J mice or
NF-ATc11/2 chimeras (Table 1; all mice examined were
5±12 weeks of age). The reduction in thymus size was
due to a significant decrease in the population ofFigure 1. Generation of ES Cell Lines Homozygous for the NF-ATc1
Mutation and Generation of NF-ATc12/2/RAG-12/2 Chimeric Mice CD41CD81 double-positive (DP) immature thymocytes
and CD41 mature thymocytes (Table 1 and Figure 2A).(A) Genomic analysis of embryonic stem cells. Genomic DNA was
isolated from NF-ATc11/1 (1/1), NF-ATc11/2 (1/2) and NF-ATc12/2 Expression of the TcRab/CD3 complex and of thymo-
(2/2) ES cells; digested with EcoRI; and analyzed by Southern cyte maturation markers such as CD69 and CD5 was
blotting using a 59 flanking probe described elsewhere (J. L. de la comparable in NF-ATc12/2 chimeric and 129/J mice
Pompa et al., submitted). Relative molecular mass markers and wild-
(data not shown).type (WT) and mutant (MT) bands are indicated.
Immature CD42CD82 double-negative (DN) thymo-(B) Homozygous mutation of NF-ATc1 in T cells. CD41 thymocytes
cytes can be classified into four distinct phenotypicfrom 129/J mice or NF-ATc12/2 chimeric mice were cell-sorted and
analyzed for wild-type (WT) or mutant (MT) alleles using PCR. precursor populations by the differential expression of
(C) Absence of NF-ATc1 transcripts in T cells of chimeric mice. Total CD25 and CD44, providing a maturational sequence of
RNA was extracted from ConA-activated peripheral T cells. Northern CD252CD441→ CD251CD441→ CD251CD442→ CD252
blots were hybridized to NF-ATc1 cDNA or b-actin cDNA probes.
CD442. Since the CD252CD442 population is an imme-(D) Differentiation of mutant ES cells into multiple organs. DNA was
diate precursor to DP thymocytes (Godfrey and Zlotnik,extracted from thymus, spleen, heart muscle, lung, liver, kidney,
1993; PeÂ nit et al., 1995; ZuÂ nÄ iga-PfluÈ cker and Lenardo,intestine, skeletal muscle, and skin of the chimeric (Ch) mice. DNA
was also extracted from wild-type (WT) spleen and thymus. Pres- 1996), theexpression of CD25 and CD44 on CD42, CD82,
ence of the mutant allele was analyzed using PCR. CD32, B2202, and Mac-12 (lineage marker±negative)
thymocytes was investigated. Compared with 129/J
or NF-ATc11/2 chimeric mice, DN thymocytes of NF-
ATc12/2 chimeric mice exhibited a lower percentagewe generated NF-ATc12/2 ES cell lines from NF-ATc11/2
ES cells by selection at an increased concentration of of CD251CD442 cells, concomitant with an increased
frequency of CD252CD442 cells (Figure 2B). Moreover,G418. Homozygous mutation of the NF-ATc1 gene was
confirmed by Southern blot analysis of ES cell clone the mutant chimeric mice had fewer CD25lowCD442 cells
(PeÂnit et al., 1995) than wild-type or heterozygous micegenomic DNA digested with EcoRI, as shown for one
ES line in Figure 1A. NF-ATc12/2 somatic chimeras were (Figure 2B). Normal CD25lowCD442 cells and CD252
CD442 cells are cycling and contain a high percentagegenerated by injecting NF-ATc12/2 mutant ES cells into
blastocysts from RAG-1-deficient (RAG-12/2) mice, con- of blastoid cells (PeÂ nit et al., 1995). However, as shown in
Figure 2B (bottom), theCD25lowCD442 and CD252CD442stituting a RAG-1±deficient blastocyst complementation
assay. Since RAG-1±deficient (or RAG-2±deficient) mice populations of NF-ATc12/2 chimeric mice contained rel-
atively low frequencies of blastoid thymocytes as deter-do not produce any mature lymphocytes because of a
block in the initiation of V(D)J recombination, mature mined by forward light scatter profiling, indicating a
loss of blastoid thymocytes in these compartments. Inlymphocytes in the somatic chimeras must be derived
from the injected NF-ATc12/2 ES cells (Mombaerts et agreement with this finding, lineage marker±negative
thymocytes of NF-ATc12/2 chimeric mice (Lin2 in Figureal., 1992; Shinkai et al., 1992; Chen et al., 1994b).
NF-ATc12/2 ES cell clones and a parental NF-ATc11/2 2C) showed a relative increase of cells in the G01G1
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Table 1. Numbers of Lymphoid Cells in NF-ATc12/2 Chimeric Mice
Absolute Numbers 6 SEM (3 1026) Percentages 6 SEM
Organ NF-ATc11/1 NF-ATc11/2 NF-ATc12/2 NF-ATc11/1 NF-ATc11/2 NF-ATc12/2
Thymus 80.5 6 13.2 95.0 6 8.0 36.0 6 9.0a
CD42CD82 4.0 6 0.9 4.8 6 0.2 7.4 6 1.5a 5.6 6 1.3 6.1 6 0.8 19.5 6 7.4
CD41CD81 68.1 6 10.0 82.2 6 3.1 19.7 6 3.5a 78.7 6 3.2 76.4 6 1.1 59.8 6 8.6
CD41CD82 10.7 6 1.6 14.8 6 0.6 5.0 6 1.5a 12.4 6 1.8 12.7 6 0.1 15.7 6 3.5
CD42CD81 2.0 6 0.7 3.7 6 0.1 1.4 6 0.8 3.5 6 1.7 4.9 6 1.7 5.1 6 3.4
Spleen 3.8 6 1.1 4.3 6 1.5 4.6 6 1.8
Lymph nodes 2.1 6 0.8 1.8 6 0.5 2.3 6 1.1
Total thymocytes, total spleen cells, and total axillar, inguinal, and mesenteric lymph node cells from NF-ATc11/1 (129/J) (n 5 8), NF-ATc11/2
chimera (n 5 6), and NF-ATc12/2 chimera (n 5 8) were isolated, counted, and analyzed for their surface marker expression. All mice analyzed
were 5±12 weeks of age.
a Statistically significant difference (Student's t test, P , 0.001) between NF-ATc12/2 and NF-ATc11/1 mice.
phase of the mitotic cell cycle compared to wild type thymocytes from NF-ATc12/2 chimeric mice (Lin1 in Fig-
ure 2C) showed cell cycle profiles similar to those of(83% vs. 67%), and a reduction of cells in the S and
G21M phases (17% and 0.0% in the mutant, respec- thymocytes from wild-type mice. Reverse transcriptase
PCR analysis of wild-type cells showed that NF-ATc1tively, vs. 33% and 0.2% in the wild type). These results
are consistent with a partial G1 block of DN thymocytes is expressed in both CD251CD442 and CD252CD442
DN thymocytes (Figure 2D), suggesting that NF-ATc isin NF-ATc12/2 chimeric mice. Lineage marker±positive
Figure 2. Flow Cytometric Analysis and Cell Cycle Analysis of Thymocytes
(A) Thymocytes were isolated from 129/J (NF-ATc11/1), NF-ATc11/2 chimeric mice or NF-ATc12/2 chimeric mice and stained with anti-CD4,
anti-CD8, and anti-Ly-9.1 antibodies. Ly-9.11 cells were analyzed for their expression of CD4 and CD8. Percentages of positive cells within
a quadrant are indicated.
(B) Thymocytes were stained with anti-CD4, anti-CD8, anti-TcRab, anti-B220, anti-Mac-1 (lineage markers), anti-CD25, anti-CD44, and anti-
Ly-9.1. Ly-9.11 lineage marker±negative populations were analyzed for their expression of CD25 and CD44. Percentages of CD251CD442,
CD25lowCD442, and CD252CD442 cell populations are indicated. Forward light scatter profiles of CD25low/2CD442 cellsin Ly-9.11 lineage
marker±negative populations are also shown.
(C) Ly-9.11 lineage marker±negative (Lin-) thymocytes were sorted and stained with propidium iodide for cell cycle analysis. Percentages of
cells in G01G1, S, and G21M phases are indicated. Ly-9.11 lineage marker±positive (Lin1) thymocytes were also analyzed as a control.
(D) CD251CD442 (CD251) or CD252CD442 (CD252) thymocytes were isolated from lineage marker±negative thymocytes from 129/J mice by
cell-sorting. Expression of the NF-ATc1 gene was analyzed using reverse transcriptase PCR analysis. The reaction was performed in the
presence (RT1) or absence (RT2) of reverse transcriptase. Expression of the glyceraldehyde-3-phosphate dehydrogenase (G3PDH) gene was
analyzed as a positive control.
Immunity
118
Figure 4. Flow Cytometric Analysis of Lymph Node, Spleen, and
Bone Marrow Cells
Single-cell suspensions of lymph node cells, spleen cells, or bone
marrow cells were stained with anti-CD4 versus anti-CD8; anti-B220
(B cell marker) versus anti-Thy1.2 (T cellmarker); or anti-B220versus
anti-CD43, respectively, and analyzed for their surface expression
by flow cytometry. Percentages of positive cells within a quadrant
are indicated. Experiments were repeated three times with similar
results.
T cells or NK11 T cells (IL-2Rb1 TcRabint cells) in the
Figure 3. Flow Cytometric Analysis of IEL andIL-2Rb1 TcRab1 Cells
thymus were observed between mutant and wild-typein the Liver
or heterozygous chimeric mice (data not shown). There(A) Single-cell suspensions of intraepithelial cells were prepared as
also were no significant differences in the numbers ofdescribed in Experimental Procedures. Cells were stained with
intestinal intraepithelial TcRgd T and TcRab T cells (Fig-FITC-conjugated anti-TcRb and PE-conjugated anti-TcRd, or FITC-
conjugated anti-CD8a and PE-conjugated anti-CD8b. ure 3A). The mutant chimeric mice also had comparable
(B) Liver MNC were prepared as described in Experimental Proce- numbers of NK11 T cells in the liver (Figure 3B). Thus,
dures. Cells were stained with FITC-conjugated anti-TcRb and PE- the absence of NF-ATc1 did not significantly affect the
conjugated anti-IL-2Rb. The numbers correspond to the proportion
development of T lineage or related cells other than thatof the total number cells within quadrants. Experiments were re-
of TCRab thymocytes.peated three times with similar results.
Impaired Proliferation of Peripheral Lymphocytes
No differences in the numbers of lymph node cells orinvolved in the expansion of CD25low/2CD442 DN thymo-
cytes. Analysisof theapoptosis of ex vivomutant thymo- spleen cells (Table 1) or in the ratio of CD41 to CD81
cells in the lymph nodes or spleen (Figure 4 and data notcytes stimulated with anti-CD95 (Fas) antibodies, anti-
CD3 6 anti-CD28 antibodies, dexamethazone, or heat shown) were observed between NF-ATc12/2 chimeric
mice and control mice. The expression of IL-2Ra (CD25),shock (418C, 30 min) did not reveal any significant differ-
ences from the wild type (data not shown), excluding CD69, CTLA-4, CD28, FasL, and CD40L as analyzed by
flow cytometric analysis was normal following mutantthe possibility that the reduced thymocyte number was
due to stress-induced cell death. T cell activation (data not shown). However, the prolifer-
ation of peripheral T cells from the chimeric mice inWe examined whether the development of unconven-
tional T cell subsets was affected by the absence of NF- response to phorbol myristate acetate (PMA) plus cal-
cium ionophore, concanavalin A (ConA), the solubleATc1. No significant differences in the numbers of TcRgd
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119
Figure 5. Proliferation and Function of Peripheral Lymphocytes
(A) Proliferation of lymph node T cells. Cells were stimulated with
PMA plus Ca21 ionophore A23617, soluble anti-CD3e, soluble anti-
CD28, or ConA in the presence or absence of IL-2 for 48 or 72 hr.
The incorporation of [3H]thymidine during the last 8 hr of culture
was measured. Experiments were performed in triplicate; shown
are the mean 1 SD for each sample. Open bars, wild-type control;
filled bars, NF-ATc2/2 chimera.
(B) Culture supernatants of the cell cultures described in (A) were
assayed in triplicate for IL-2 production by ELISA. Experiments were
repeated four times with similar results. Bars as in (A).
(C) Proliferation of spleen B cells. Spleen cells depleted of red blood
cells were stimulated with PMA plus Ca21 ionophore A23617, anti-
IgM, anti-CD40, or LPS in the presence or absence of IL-4 for 48
or 72 hr. The incorporation of [3H]thymidine during the last 8 hr of
culture was measured. Experiments were performed in triplicate
and repeated three times. Bars as in (A).
(D) Basal serum immunoglobulin concentrations. The serum con-
centrations of different immunoglobulin subclasses were deter-
mined by ELISA. Open squares, heterozygous chimera; closed
squares, homozygous chimera. Experiments were performed in du-
plicate and repeated twice using two mice per group per experiment.
(E) Immunoblot analysis of STAT5a, STAT5b, and IRF-4 expression. Spleen cells from two heterozygous (1/2) or two homozygous (2/2)
mutant chimeras were cultured for 48 hr with anti-CD3 (0.5 mg/ml) in the absence of cytokines (shown as CD3), or in the presence of 50 U/ml
IL-2 (CD3 1 IL-2) or 400 U/ml IL-4 (CD3 1 IL-4), or without treatment (None). Cell lysates were prepared as described in Experimental
Procedures and immunoblot analyses were performed using specific antibodies.
form of anti-CD3 6 anti-CD28, SEB, or allogeneic stimu- resulting in reduced proliferation of mutant T lympho-
cytes is intrinsic to the cells themselves and is not duelation reached only approximately 70% of the level of
proliferation of cells from wild-type or heterozygous chi- to impaired IL-2 production.
Development of B cells in the bone marrow and spleenmeric mice (Figure 5A and data not shown). This pro-
liferation defect of mutant T lymphocytes was not fully of the chimeric mice appeared normal (Figure 4). No
anomalies in the total numbers or percentages of B2201rescued by the addition of exogenous IL-2 (50 U/ml),
although some response was observed. Moreover, stim- B cells in the spleen or lymph nodes were observed
(Figure 4 and data not shown). However, in response toulated T cells from homozygous chimeric and wild-type
mice showed no differences in the level of IL-2 secreted PMA plus calcium ionophore, anti-immunoglobulin M
(anti-IgM), or anti-CD40, Bcells from NF-ATc12/2 chime-in supernatants in these primary stimulating cultures
(Figure 5B). These data show both that NF-ATc1 is not ric mice showed only approximately 50%±60% of the
proliferation of wild-type or heterozygous B cells (Figureessential for the production of IL-2 and that the defect
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5C). The impaired response was not rescued by the and tumor necrosis factor-a (TNFa) (Figure 6). These
data demonstrate that the absence of NF-ATc1 duringaddition of exogenous IL-4 (400 U/ml). There was no
significant difference in the proliferation of mutant B an ongoing immune response impairs the establishment
of the Th2 response but does not affect the establish-cells in response to lipopolysaccharide (LPS) in the ab-
sence or presence of IL-4. Serum concentrations of total ment of the Th1 response.
immunoglobulin were comparable between NF-ATc12/2
and NF-ATc11/2 chimeric mice (data not shown). How- Discussion
ever, the homozygous mutant chimeric mice showed
slightly elevated levels of IgM and IgG2a compared with The development and responses of the immune system
are coordinated by an interacting network of transcrip-heterozygous mutant chimeric mice, but slightly re-
duced levels of IgG1(Figure 5D). The NF-ATc12/2 chime- tion factors involved in the expression of effector pro-
teins such as cytokines (Crabtree, 1989; Paul and Seder,ric mice produced neutralizing antibodies (IgM and IgG)
against vesicular stomatitis virus at levels similar to 1994; Zlotnik and Moore, 1995; Clevers and Grosschedl,
1996). The NF-AT family of transcription factors hasthose in wild-type mice (data not shown). The chimeric
mice also developed comparable cytotoxic T lympho- been reported to play a critical role in this process. Our
analyses of NF-ATc12/2/RAG-12/2 somatic chimeras in-cyte responses to the virus (data not shown). NF-ATc1
is thus not essential for the helper function of T cells in dicate that NF-ATc1 is required for the development of
T lymphocytes, the proliferation of lymphocytes, andvivo.
To investigate further the mechanism underlying the the production of Th2 cytokines.
The development of thymocytes from precursors toIL-2±resistant defect in the proliferation of mutant T lym-
phocytes, we examined the expression of the transcrip- mature T cells is tightly regulated by the expression and
cooperation of multiple molecules, the identity of whichtion factors STAT5a and STAT5b (signal transducers
and activators of transcription 5a and 5b), molecules depends on a given developmental stage (Godfrey and
Zlotnik, 1993; Zlotnik and Moore, 1995; ZuÂ nÄ iga-PfluÈ ckerinvolved in the IL-2±mediated signal transduction path-
way (Gilmour et al., 1995; Hou et al., 1995; Lin et al., and Lenardo, 1996). NF-ATc1 has a specific function in
the proliferative expansion of CD25low/2CD442CD421996). The expression of STAT5a and STAT5b was com-
parable in anti-CD3±stimulated lymphocytes of hetero- CD82CD32 triple-negative (TN) thymocytes, an immedi-
ate precursor population for DP thymocytes. This cellzygous and homozygous mutant chimeric mice (Figure
5E) and was not altered in the presence of IL-2 or IL-4. population is unable to produce IL-4 or IL-2 (Godfrey
and Zlotnik, 1993; Zlotnik and Moore, 1995), indicatingWe also examined the expression of the transcription
factor interferon regulatory factor-4 (IRF-4), since the a requirement for the involvement of other molecule(s)
whose transcription is controlled by NF-ATc1. Disrup-disruption of the IRF-4 gene resulted in a similar but
more profound impairment of T and B cell proliferation tion of the transcription factor T cell factor-1 gene (Tcf-1)
(Verbeek et al., 1995) or functional inactivation of Rhothat also could not be rescued by the addition of exoge-
nous IL-2 or IL-4 (Mittrucker et al., 1997). No significant GTPase (Galandrini et al., 1997; Henning et al., 1997) in
the thymus resulted in similar but more drastic impair-differences in the induction or expression of IRF-4 were
recorded after the stimulation of mutant T cells with ments of the proliferative expansion of immature thymo-
cytes. In addition, disruption of the transcription factoranti-CD3 (Figure 5E).
SOX-4 gene produced cardiac malformations similar to
those observed in NF-ATc12/2 mutant embryos (unpub-
Impaired Production of Th2 Cytokines lished data), as well as a profound defect in B cell de-
by NF-ATc12/2 T Cells velopment (Schilham et al., 1996) and compromised ex-
NF-ATc2, a member of the cytoplasmic NF-AT family, pansion of thymocytes in fetal thymic organ cultures
appears to be involved in Th2 development, since dis- (Schilham et al., 1997). Together, these data suggest
ruption of the NF-ATc2 gene results in augmented pro- that a common signaling pathway(s) that is critical for
duction of IL-4 by T cells that had differentiated into the proliferative expansion of thymocytes may exist
Th2 cells (Hodge et al., 1996), or the accumulation of downstream of these transcription factors.
eosinophils accompanied by an elevated level of IgE Despite the impaired proliferation of thymocyte pro-
(Xanthoudakis et al., 1996). To investigate the role of genitors, the development of TcRgd T cells in the thymus
NF-ATc1 in the development of Th cell responses, we and the intestine, and the development of NK11 T cells
examined the response of NF-ATc12/2 T cells to two in the thymus and the liver of NF-ATc12/2 chimeras ap-
different stimuli known to induce the differentiation of peared normal (Figures 3A and 3B and data not shown).
T cells into either the Th1 or Th2 type. NF-ATc12/2 spleen Since CD251CD442 TN thymocytes are known to be the
T cells stimulated with anti-CD3 in the presence of IL-4 last precursor population that gives rise to TcRgd T cells
(which normally induces Th2 differentiation) showed de- and NK11 T cells (Godfrey and Zlotnik, 1993; ZuÂ nÄ iga-
creased IL-4 production compared to wild-type T cells PfluÈ cker and Lenardo, 1996), the normal development
(Figure 6). Mutant spleen cells also produced less IL-6 of TcRgd T cells and NK11 T cells in the thymus, small
than wild-type cells in the same experiments. In con- intestine, and liver of homozygous chimeric mice indi-
trast, when mutant T cells were stimulated with anti- cates that the proliferative expansion of the CD251
CD3 in the presence of IL-12 (which normally induces CD442 TN thymocyte population is intact in NF-ATc12/2
Th1 responses), there were no differences between ho- chimeric mice.
mozygous and heterozygous chimeric cells in the pro- NF-ATc1 is also involved in the proliferation of periph-
eral T lymphocytes and B lymphocytes (Figures 5A andduction of the Th1-type cytokines interferon-g (IFNg)
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Figure 6. Differentiation In Vitro of T Cells
into Th1 or Th2
Spleen cells (1 3 106/ml) were stimulated with
10 mg/ml plate-bound anti-CD3e in the pres-
ence of 1 ng/ml IL-12 for Th1 differentiation
or 1000 U/ml IL-4 for Th2 differentiation. Cul-
tured cells were fed with fresh medium after
4 days, and an equal number of viable cells
(0.5 3 106/ml/sample) after 7 days were re-
stimulated with plate-bound anti-CD3 in the
absence of any additional cytokines. Super-
natants were collected 24 hr later and IL-4
and IL-6 or IFNg and TNFa in the superna-
tants of Th2- or Th1-differentiated cells, re-
spectively, were measured by ELISA. Shown
are representative results of four replications
of these experiments.
5C). The molecular basis of the role of NF-ATc1 in cell be involved in the mechanism(s) that determines the
proliferation is currently unknown but cannot be totally Th2 response. The transcription factor GATA-3 has been
dependent on cytokine production, since exogenous shown to be selectively expressed in differentiating and
cytokines (IL-2 for T cells and IL-4 for B cells) did not effector Th2 cells and required for the transcription of
rescue the proliferation defect in NF-ATc12/2 lympho- all Th2 cytokine genes (Zheng and Flavell, 1997). The
cytes (Figures 5A and 5C). The expression of the tran- expression of GATA-3 in activated homozygous mutant
scription factors STAT5a, STAT5b, and IRF-4, all of spleen cells, however, was unaffected (data not shown).
which are involved in lymphocyte proliferation, was not We also examined the expression of the transcription
altered in the mutant lymphocytes (Figure 5E). Thus, the factor IRF-1, since the disruption of the IRF-1 gene re-
role(s) of NF-ATc1 in the proliferation of cells may reside sulted in compromised establishment of Th1 responses
in a pathway distinct from those involving STAT5 or concomitant with augmented production of IL-4 by mu-
IRF-4. This study has also demonstrated that NF-ATc1 tant cells (Lohoff et al., 1997; Taki et al., 1997), but the
is not essential for the production of IL-2 (Figure 5B), expression of IRF-1 in activated mutant spleen cells was
but our results do not exclude the possibility that NF- also unaffected (data not shown). These data indicate
ATc1 is involved in some way. Since the four members that a distinct mechanism(s) of Th cell differentiation
of the NF-AT family have overlapping DNA-binding and may be exploited by NF-AT members.
transcriptional specificities (McCaffrey et al., 1993a, In contrast to the impaired establishment of the Th2
1993b; Northrop et al., 1994; Ho et al., 1995; Hoey et al., response in NF-ATc12/2 T cells, targeted disruption of
1995; Masuda et al., 1995; Rao et al., 1997), a functional NF-ATc2 resulted in the enhancement of Th2 responses
redundancy of NF-AT activities could explain the pro- (Hodge et al., 1996; Xanthoudakis et al., 1996). Thus, the
duction of IL-2, at least in primary cultures, in NF- balance between NF-AT family members with distinct,
ATc12/2 T cells. The establishment of cytotoxic T lym- nonoverlapping functions may becritical in thecontrol of
phocyte responses and the T-dependent production of gene expression and the development of T cell function
neutralizing antibodies against vesicular stomatitis virus during ongoing immune responses (Rooney et al., 1994;
infection were also intact in chimeric mice. Rincon and Flavell, 1997a, 1997b). Expression of NF-
CD41 T cells potentiate the inflammatory or humoral
ATc1 as well as NF-ATc2 has been reported in NK11 T
immune response to bacterial, parasitic, and viral infec-
cells (Hodge et al., 1996), a population responsible for
tions through the Th1 or Th2 responses, respectively
IL-4 production in response to challenge in vivo with
(Mosmann et al., 1986; Mosmann and Coffman, 1989;
anti-CD3 (Carding et al., 1991; Sen et al., 1994; Yoshi-Scott and Kaufmann, 1991; Mosmann and Sad, 1996).
moto and Paul, 1994; Yoshimoto et al., 1995). TheseThe differentiation of naive CD41 T cells into Th1 or Th2
data imply that both NF-ATc1 and NF-ATc2 may becells appears to be a multistep process controlled by
involved in the production of IL-4 and the resulting biascytokines produced during the immune response. In
toward Th2 differentiation (Hodge et al., 1996). NF-ATc1particular, IL-12 induces differentiation into Th1 cells,
mutant chimeric mice had comparable numbers of NK11whereas IL-4 induces differentiation into Th2 cells (Se-
T cells in the liver and the thymus (Figure 3B and data notder et al., 1992, 1993; Paul and Seder, 1994; Paul, 1997).
shown), but theabsence of NF-ATc1may have adverselyThe molecular mechanisms by which the activation of
affected the ability of this population to produce IL-4.T cells drives Th1 and Th2 effector cell differentiation
Our analyses of NF-ATc12/2 chimeric mice indicateare poorly understood, although the contributions of
that NF-ATc1 has critical functions in the developmentseveral different transcription factors have been re-
of T cells, the proliferation of lymphocytes, and the es-ported (Kaplan et al., 1996; Takeda et al., 1996; Lohoff
tablishment of the Th2 response. The specific roles ofet al., 1997; Taki et al., 1997; Zheng and Flavell, 1997).
other members of the NF-AT family at distinct stagesIn this study, the development of Th2 responses in vitro
of lymphocyte development and in lymphocyte activa-was compromised in the absence of NF-ATc1, whereas
tion will no doubt be clarified by the generation of miceTh1 cytokine production was not altered in the mutant
cells (Figure 6), providing evidence that NF-ATc1 may deficient for these molecules.
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Experimental Procedures obtained from small intestine or liver were likewise stained with anti-
TcRb and anti-TcRd or anti-CD8a and anti-CD8b for IEL or anti-
TcRb and anti-IL-2Rb for liver MNC. Experiments were repeatedGeneration of the NF-ATc12/2 ES Cell Lines
The establishment of ES cell lines heterozygous for the NF-ATc1 three times with similar results.
exon 3 mutation is described elsewhere (J. L. de la Pompa et al.,
submitted). For the generation of NF-ATc12/2 ES cell lines, G418- Cell Cycle Analysis
resistant NF-ATc11/2 ES clones were cultured at an increased con- For cell cycle analysis, Ly-9.11 lineage marker±negative thymocytes
centration of G418 (2 mg/ml, Gibco±BRL, Grand Island, NY). Screen- were cell-sorted. Cells were suspended in 1 ml of FCS followed by
ing for the homozygous mutation was carried out by PCR. Primers the addition of 1 ml of Iscove's modified Dulbecco's medium. Ice-
used were 59-GAT GGT CTG CCT AGT CAT GAA A-39 and 59-CTT cold 70% ethanol (6 ml) was added dropwise to a final concentration
CCT CGT GCT TTA CGG TAT C-39, specific for the wild-type NF- of 50% to permeabilize the cellmembrane. After 30 min of incubation
ATc1 allele, and 59-CAC GTC GTG GAA AAA CTG TC-39, specific at 48C, cells were centrifuged and stained for 30 min at 48C with
for the neomycin resistance gene. Genomic DNA samples were propidium iodide (50 mg/ml) in the presence of RNase (500 mg/ml)
digested with EcoRI and analyzed by Southern blot. Of 48 colonies, to visualize cellular DNA. Cell cycle analysis was performed with
two showed homozygous mutation of NF-ATc1 exon 3. Both homo- ModFit LT software (Becton Dickinson).
zygous mutant cell lines contributed to the reconstitution of T and B
cell compartments in RAG-1±deficient blastocyst complementation Reverse Transcriptase±PCR
assays and showed similar phenotypes. CD251CD442 and CD252CD442 populations from 129/J mice were
isolated from lineage marker±negative thymocytes by cell-sorting.
RAG-1±Deficient Blastocyst Complementation Assay Total RNA was extracted with Trizol solution (Gibco±BRL), reverse-
For the generation of chimeric mice, two NF-ATc12/2 ES cell clones transcribed with a first-strand cDNA synthesis kit (Pharmacia Bio-
and a parental NF-ATc11/2 ES cell clone were injected into 3.5- tech, Uppsala, Sweden) using random primers, and amplified for
day RAG-12/2 blastocysts and were transferred to pseudopregnant NF-ATc1 gene expression using PCR. Primers used for amplification
foster mothers. Mice were maintained under pathogen-free condi- were: 59 primer, 59-GCA AGC ATC ACG GAG GAG AGC-39; and 39
tions in accordance with the guidelines of the Canadian Medical primer, 59-CGG GTG GGA AGT CAG AAG TGG-39. As a positive
Research Council. Peripheral blood of the chimeric mice was ana- control, the glyceraldehyde-3-phosphate dehydrogenase (G3PDH)
lyzed for the reconstitution of mature T and B lymphocytes by flow gene was amplified with a specific primer pair. As a negative control,
cytometric analysis. CD41 thymocytes were cell-sorted and ana- the reaction was performed in the absence of reverse transcriptase.
lyzed for the presence of wild-type and mutant alleles by PCR using
the primers described above. Total RNA extracted from column- Cell Proliferation Assay
purified T cells from control or mutant chimeric mice was electro- For the T cell proliferation assay, lymph node cells (1 3 105 cells/
phoresed, blotted, and hybridized to an NF-ATc1 cDNA probe. well) were placed into round-bottom 96-well plates and activated
with PMA (12.5 ng/ml, Sigma, St. Louis, MO) plus Ca21 ionophore
A23617 (100 ng/ml), soluble anti-CD3e (0.2 mg/ml), soluble anti-CD28Cell Preparation
(0.1 mg/ml), or ConA (1.25 mg/ml) in the presence or absence of IL-2Mononuclear cells (MNC) from thymus, spleen, lymph node, and
(50 U/ml). Cells were harvested at 48 or 72 hr after an 8 hr pulsebone marrow were obtained by standard methods. To obtain liver
with [3H]thymidine (1 mCi/well). The incorporation of 3H-thymidineMNC, the liver was pressed through stainless steel mesh and sus-
was measured with a b-counter. T cell culture supernatants werepended in 50 ml of phosphate-buffered saline (PBS). After one wash
assayed in triplicate for IL-2 by enzyme-linked immunosorbentin PBS, the cells were fractionated by discontinuous (40% and 80%)
assay (ELISA) (Genzyme Diagnostics, Cambridge, MA).Percoll gradient centrifugation for 10 min at 900 3 g. The interface
For the B cell proliferation assay, spleen cells were depleted ofwas harvested and washed with 5% fetal calf serum (FCS)±PBS
Thy1.21 T cells with anti-Thy1.2 antibodies (clone AT83) and rabbitprior to use in experiments. To obtain intraepithelial lymphocytes
complement (Cedarlane, Ontario, Canada). Viable B cells were iso-(IEL), small intestine dissected free of Peyer's patches was incised
lated with Lympholite M (Cedarlane), and cells (1 3 105 cells/well)longitudinally, washed with PBS, and cut into 5 mm pieces. These
were placed into round-bottom 96-well plates and activated withpieces were incubated in PBS with stirring for 20 min at 378C. The
PMA plus Ca21 ionophore, anti-IgM (20 mg/ml), anti-CD40 (1 mg/ml),supernatant, containing IEL and epithelial cells, was washed with
or LPS (20 mg/ml), in the presence or absence of IL-4 (400 U/ml).5% FCS-PBS and fractionated as above by discontinuous Percoll
[3H]Thymidine incorporation was measured as described above.gradient centrifugation for 10 min at 900 3 g. The interface was
harvested and washed with 5% FCS-PBS.
ELISA for Immunoglobulin Subclasses
ELISA for immunoglobulin subclasses were performed on seriallyFlow Cytometric Analysis
diluted serum samples using anti-mouse immunoglobulin (IgG 1Single-cell suspensions of thymocytes from 129/J NF-ATc11/2 chi-
IgA 1 IgM) antibodies and alkaline phosphatase±conjugated anti-meric mice or NF-ATc12/2 chimeric mice were stained with phycoer-
mouse immunoglobulin isotype antibodies (Southern Biotechnologyythrin (PE)±conjugated anti-CD4, fluorescein isothiocyanate (FITC)±
Associates, Birmingham, AL) according to the manufacturer's direc-conjugated anti-CD8 and biotin-conjugated anti-Ly-9.1 antibodies
tions. ELISA for IgE was performed using anti-IgE antibody (Phar-(PharMingen, San Diego, CA), followed by staining with streptavidin-
Mingen) and alkaline phosphatase±conjugated anti-IgE antibodyconjugated RED670 (Gibco±BRL) and analysis of the expression
(Southern Biotechnology Associates).of surface markers using a flow cytometer (FACScalibur, Becton
Dickinson, San Jose, CA). The mutant ES cell lines used in the
experiments were derived from strain 129 mice that are positive for Western Blot Analysis
Stimulated and unstimulated spleen cells from homozygous or het-the Ly-9.1 marker. The host RAG-12/2 cells are negative for Ly-9.1,
so Ly-9.11 cells from the chimeric mice were analyzed. erozygous chimeric mice were lysed in a buffer containing 50 mM
Tris (pH 7.5); 1% Triton-X; 150 mM EDTA; 150 mM NaCl; and 1 mg/For the analysis of thymocyte precursors, single-cell suspensions
of thymocytes from NF-ATc12/2 chimeric, NF-ATc11/2 chimeric, and ml each of aprotinin, leupeptin, phenylmethylsulfoxidefluoride, and
sodium orthovanadate.After a standardprotein assay (Pierce, Rock-129/J control mice were stained with allophycocyanin-conjugated
anti-CD4, anti-CD8, anti-TcRab, anti-B220, and anti-Mac-1; PE-con- ford, IL), 20 mg of total protein from each sample was separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis, trans-jugated anti-CD44; biotin-conjugated anti-CD25; and FITC-conju-
gated anti-Ly-9.1, followed by staining with streptavidin-conjugated ferred onto a nitrocellulose membrane, and Western blotted for the
presence of STAT5a and STAT5b, IRF-4, and actin as a control toRED670. Ly-9.11 lineage marker±negative populations were ana-
lyzed for their expression of CD44 and CD25. ensure equal protein loading. Rabbit polyclonal antibodies against
STAT5a and STAT5b (Zymed Laboratories, San Francisco, CA) andSingle-cell suspensions of lymph node cells, spleen cells, and
bone marrow cells were stained with anti-CD4 and anti-CD8, anti- actin (Sigma) were used according to the manufacturer's guidelines,
and anti-IRF-4 was used at a dilution of 1:500. Donkey anti-rabbitB220 and anti-IgM, or anti-B220 and anti-CD43, respectively. MNC
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horseradish peroxidase antibody (Amersham, Ontario, Canada) and Identification of a novel cyclosporin-sensitive element in the human
tumor necrosis factor alpha gene promoter. J. Exp. Med. 178, 1365±enhanced chemiluminescence (Amersham) were used for visual-
1379.ization.
Henning, S.W., Galandrini, R., Hall, A., and Cantrell, D.A. (1997). The
In Vitro T Cell Differentiation Assay GTPase Rho has a critical regulatory role in thymus development.
EMBO J. 16, 2397±2407.For in vitro T cell differentiation assays, spleen cells (1 3 106 cells/
ml) depleted of red blood cells were cultured in duplicate in Iscove's Ho, S.N., Thomas, D.J., Timmerman, L.A., Li, X., Francke, U., and
modified Dulbecco's medium and stimulated with 10 mg/ml plate- Crabtree, G.R. (1995). NFATc3, a lymphoid-specific NFATc family
bound anti-CD3e in the presence of 1 ng/ml IL-12 for Th1 differentia- member that is calcium-regulated and exhibits distinct DNA binding
tion or 1000 U/ml IL-4 for Th2 differentiation. Cultured cells were specificity. J. Biol. Chem. 270, 19898±19907.
fed with fresh medium after 4 days of culture. Cells were collected Ho, S., Clipstone, N., Timmermann, L., Northrop, J., Graef, I., Fioren-
after 7 days and washed, and an equal number of viable cells (0.5 3 tino, D., Nourse, J., and Crabtree, G.R. (1996). The mechanism of
106 cells/ml) was restimulated with plate-bound anti-CD3e in the action of cyclosporin A and FK506. Clin. Immunol. Immunopathol.
absence of any additional cytokines. Supernatants were collected 80, S40±S45.
24 hr later, and the production of IL-4 and IL-6 in the Th2 differentia- Hodge, M.R., Ranger, A.M., Charles de la Brousse, F., Hoey, T.,
tion culture or IFNg and TNFa in the Th1 differentiation culture was Grusby, M.J., and Glimcher, L.H. (1996). Hyperproliferation and dys-
measured in duplicate by ELISA (Genzyme and Endogen, Woburn, regulation of IL-4 expression in NF-ATp±deficient mice. Immunity
MA). 4, 397±405.
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